减少中药基本药物不良反应的探讨

Reduction of ADRs of essential traditional Chinese medicines

中药基本药物是我国基本药物目录的特色所在,应充分发挥中药基本药物的独特优势,发挥其"保基本"的重要作用。中药基本药物具有特殊性,同时也具有药品的两重性,不良反应不可避免,但可以通过控制某些条件来尽量减少其不良反应发生的可能。在基本药物制度框架下,针对中药基本药物遴选,中药基本药物自身及其生产、流通和使用环节等分析有可能增加其不良反应发生的各种因素,提出减少其不良反应发生的对策将具有重要意义。该研究以中药基本药物为研究对象,研究结果在一定程度上对普通中药也具有适用性。

The essential traditional Chinese medicines（ ETCM） are the characteristics of our National Essential Medicine List（NEML） and we should give full play to its unique advantage. The essential medicines of ETCM are specific,but also have dual characters,namely efficacy and ADRs. Although ADRs cannot be avoided,we can make efforts to control some conditions to minimize the possibility of ADRs. It is significant to give suggestions to reduce ADRs of ETCM under the ETCM system by analyzing the possibility of ADRs during ETCM selection,production distribution and use. This research focuses on ETCM,and the conclusion is also applicable to common traditional Chinese medicines.